Encysive Pharmaceuticals

Endothelin receptor antagonist for the treatment of pulmonary arterial hypertension.

placeHouston, Texas, United States calendar_todayFounded 1990 groups148 employees language encysive.com

Investor mix

1 investor on record.

Investor typeCountShare
Private equity1100%
Coming soon